DN Lester SC . Atypical ductal hyperplasia and ductal carcinoma in situ as revealed by large-core needle breast biopsy: Results of surgical excision . AJR Am J Roentgenol 2000 ; 175 : 1341 – 1346 . 36 Jackman RJ Burbank F Parker SH
Search Results
Point: Sentinel Lymph Node Biopsy Is Indicated for Patients With DCIS
Hiram S. Cody III and Kimberly J. Van Zee
Counterpoint: Sentinel Lymph Node Biopsy Is Not Indicated for Ductal Carcinoma In Situ
Stephen B. Edge and David G. Sheldon
Lagios MD Silverstein MJ . Sentinel node biopsy for patients with DCIS: A dangerous and unwarranted direction . Ann Surg Oncol 2001 ; 8 : 275 – 277 . 47 Burbank F . Stereotactic breast biopsy of atypical ductal hyperplasia and ductal
Ewing Sarcoma in a Patient With Cowden Syndrome
Mod C. Chandhanayingyong, Nicholas M. Bernthal, Piti Ungarreevittaya, Scott D. Nelson, Sant P. Chawla, and Arun S. Singh
hyperplasia. The patient was doing well until she developed right-sided hip pain in July 2012 that was thought to be exercise-related. In October 2013, she had a fall that exacerbated this hip pain. Radiographic findings showed a fracture of her iliac wing
Management of Extramedullary Leukemia as a Presentation of Acute Myeloid Leukemia
Samuel J. Slomowitz and Paul J. Shami
myeloid sarcoma is generally estimated at 2% to 9% in most series. 13 Others have estimated it to be higher. 1 This discrepancy in terms of incidence is explained partly by whether gum hyperplasia is considered myeloid sarcoma without histologic evidence
Impact of Genetic Counseling on Patient-Reported Electronic Cancer Family History Collection
Rebecca A. Vanderwall, Alison Schwartz, Lindsay Kipnis, Catherine M. Skefos, Samantha M. Stokes, Nizar Bhulani, Michelle Weitz, Rebecca Gelman, Judy E. Garber, and Huma Q. Rana
cancer, and 11 (3.3%) had other benign tumors (lobular carcinoma in situ, uterine polyps, atypical ductal hyperplasia/atypical lobular hyperplasia, endometrial intraepithelial neoplasm). Prior personal GT was self-reported in 132 (12%) pre-GC pedigrees
Clinical Assessment of Breast Cancer Risk Based on Family History
Kaylene Ready and Banu Arun
hyperplasia [ADH], atypical lobular hyperplasia [ALH], lobular carcinoma in situ [LCIS]), age at menarche, parity, breast feeding, diethylstilbestrol (DES) exposure, early breast radiation, hormone replacement therapy, obesity, alcohol intake, family history
Establishing Consensus for Mohs Micrographic Surgical Techniques in the Treatment of Melanoma in Situ for Future Clinical Trials: A Modified Delphi Study
Kristen K. Curtis, Nathan J. Fakult, Jennifer L. Strunck, Sumaira Z. Aasi, Christine S. Ahn, Murad Alam, Anna A. Bar, Ramona Behshad, Christopher K. Bichakjian, Diana Bolotin, Susan L. Boone, Jeremy S. Bordeaux, Jerry D. Brewer, David R. Carr, John A. Carucci, Jason R. Castillo, Sean R. Christensen, Melanie A. Clark, Lindsey K. Collins, Addison M. Demer, Daniel B. Eisen, Hao Feng, Bahar F. Firoz, Roy C. Grekin, Jason M. Hirshburg, Todd E. Holmes, Conway C. Huang, Thomas A. Jennings, Shang I. Brian Jiang, Sailesh Konda, Justin J. Leitenberger, Jesse M. Lewin, Ian A. Maher, Elise Ng, Ida F. Orengo, Faramarz H. Samie, Drew K. Saylor, Victoria Rose Sharon, Teo Soleymani, Susan M. Swetter, Jesalyn A. Tate, Marta J. Van Beek, Nahid Y. Vidal, Alok Vij, Ashley Wysong, Yaohui Gloria Xu, Bryan T. Carroll, and Wesley Y. Yu
background melanocytic hyperplasia and true MIS may be difficult with frozen sectioning. 26 A recent Delphi study reported consensus with 83% agreement that staged surgical excision with margin control is the most appropriate treatment for the lentigo
Uterine Neoplasms, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology
Wui-Jin Koh, Nadeem R. Abu-Rustum, Sarah Bean, Kristin Bradley, Susana M. Campos, Kathleen R. Cho, Hye Sook Chon, Christina Chu, David Cohn, Marta Ann Crispens, Shari Damast, Oliver Dorigo, Patricia J. Eifel, Christine M. Fisher, Peter Frederick, David K. Gaffney, Suzanne George, Ernest Han, Susan Higgins, Warner K. Huh, John R. Lurain III, Andrea Mariani, David Mutch, Christa Nagel, Larissa Nekhlyudov, Amanda Nickles Fader, Steven W. Remmenga, R. Kevin Reynolds, Todd Tillmanns, Stefanie Ueda, Emily Wyse, Catheryn M. Yashar, Nicole R. McMillian, and Jillian L. Scavone
their fertility. 145 – 149 Likewise, it may also be selectively used for young patients with endometrial hyperplasia who desire fertility preservation. The guidelines include an algorithm for fertility-sparing therapy in selected patients with biopsy
NCCN Guidelines® Insights: Breast Cancer Screening and Diagnosis, Version 1.2023
Featured Updates to the NCCN Guidelines
Therese B. Bevers, Bethany L. Niell, Jennifer L. Baker, Debbie L. Bennett, Ermelinda Bonaccio, Melissa S. Camp, Sona Chikarmane, Emily F. Conant, Mohammad Eghtedari, Meghan R. Flanagan, Jeffrey Hawley, Mark Helvie, Linda Hodgkiss, Tamarya L. Hoyt, Jennifer Ivanovich, Maxine S. Jochelson, Swati Kulkarni, Rachael B. Lancaster, Caitlin Mauer, Jessica Maxwell, Bhavika K. Patel, Mark Pearlman, Liane Philpotts, Donna Plecha, Jennifer K. Plichta, Shadi Shakeri, Mary Lou Smith, Clarie L. Streibert, Roberta M. Strigel, Lusine Tumyan, Nicole S. Winkler, Dulcy E. Wolverton, Mary Anne Bergman, Rashmi Kumar, and Katie Stehman
) those who have a lifetime risk ≥20% based on history of atypical ductal hyperplasia (ADH); (5) those who have a lifetime risk ≥20% based on history of lobular carcinoma in situ (LCIS) or atypical lobular hyperplasia (ALH); and (6) those with a known
Partial Response to Ceritinib in a Patient With Abdominal Inflammatory Myofibroblastic Tumor Carrying a TFG-ROS1 Fusion
Yong Li, Xian Chen, Yanchun Qu, Jia-Ming Fan, Yan Li, Hui Peng, Yaojie Zheng, Yihong Zhang, and Hai-Bo Zhang
polypoid hyperplasia in the large intestine seen on colonoscopy. PET scan showed enhanced FDG-avid uptake in the retroperitoneum, suggesting a malignant tumor in the abdomen. The patient was subsequently referred to our hospital, where she underwent
